Chronic allograft nephropathy--immunologic and nonimmunologic factors

Area of Science:

• Nephrology
• Transplantation Immunology

Background:

• Chronic Allograft Nephropathy (CAN) is a leading cause of kidney transplant loss.
• CAN results from a complex interplay of immunologic and non-immunologic factors.
• Understanding these factors is crucial for improving long-term graft survival.

Purpose of the Study:

• To review the causes and histopathological features of CAN.
• To discuss current management strategies for preventing kidney transplant loss due to CAN.
• To highlight the importance of personalized immunosuppressive therapy and comorbidity management.

Main Methods:

• Literature review of immunologic and non-immunologic factors contributing to CAN.
• Analysis of histopathological findings in different phases of CAN.
• Evaluation of therapeutic interventions for managing CAN.

Main Results:

• Immunologic factors include acute rejection, HLA mismatch, and inadequate immunosuppression.
• Non-immunologic factors comprise delayed graft function, ischemia-reperfusion injury, calcineurin inhibitor nephrotoxicity, hyperfiltration, hypertension, and hyperlipidemia.
• Histopathology shows tubulointerstitial infiltration early, progressing to arteriolar hyalinosis and glomerulosclerosis.

Conclusions:

• Modifying immunosuppressive treatment, such as reducing calcineurin inhibitors and adding non-nephrotoxic agents (mycophenolate mofetil, sirolimus), can prevent graft loss.
• Effective management of hypertension and hyperlipidemia is essential for preserving kidney allograft function.
• A comprehensive approach addressing both immune and non-immune factors is vital for combating CAN.